clindamycin has been researched along with Adverse Drug Event in 8 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (25.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (25.00) | 29.6817 |
2010's | 3 (37.50) | 24.3611 |
2020's | 1 (12.50) | 2.80 |
Authors | Studies |
---|---|
Ding, D; Fang, H; Kelly, R; Liu, Z; Shi, Q; Tong, W | 1 |
Hardjo Lugito, NP; Jayadi, NN; Kristiani, E; Kurniawan, A | 1 |
Baddour, LM; Dayer, MJ; Jones, S; Lockhart, PB; Prendergast, B; Thornhill, MH | 1 |
Calvarese, B; Chen, D; Thiboutot, D; Webster, G; Weiss, J; Zaenglein, A | 1 |
Androudi, S; Bhaila, I; Fiore, T; Iaccheri, B; Janjua, S; Papadaki, T; Stephen Foster, C | 1 |
Barker, JN; Capon, F; Creamer, D; Mockenhaupt, M; Navarini, AA; Roujeau, JC; Sekula, P; Setta-Kaffetzi, N; Simpson, MA; Smith, CH; Trembath, RC; Valeyrie-Allanore, L | 1 |
Venning, GR | 1 |
Gysling, E | 1 |
1 trial(s) available for clindamycin and Adverse Drug Event
Article | Year |
---|---|
An aqueous gel fixed combination of clindamycin phosphate 1.2% and benzoyl peroxide 2.5% for the once-daily treatment of moderate to severe acne vulgaris: assessment of efficacy and safety in 2813 patients.
Topics: Acne Vulgaris; Adolescent; Adult; Aged; Benzoyl Peroxide; Child; Clindamycin; Drug Combinations; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Male; Middle Aged; Treatment Outcome | 2008 |
7 other study(ies) available for clindamycin and Adverse Drug Event
Article | Year |
---|---|
Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps).
Topics: Animals; Anti-Infective Agents; Anti-Inflammatory Agents; Chemical and Drug Induced Liver Injury; Databases, Factual; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Models, Biological; Predictive Value of Tests | 2011 |
Immune-Mediated Adverse Drug Reactions (IM-ARDs) in the Form of Drug-Induced Immune Thrombocytopenia and Cutaneous Adverse Drug Reactions (CARD) Due to Clindamycin in an Human Immunodeficieny Virus (HIV) Patient.
Topics: Adult; Clindamycin; Drug-Related Side Effects and Adverse Reactions; HIV Infections; Humans; Male; Purpura; Purpura, Thrombocytopenic, Idiopathic; Thrombocytopenia | 2023 |
Incidence and nature of adverse reactions to antibiotics used as endocarditis prophylaxis.
Topics: Amoxicillin; Anti-Bacterial Agents; Antibiotic Prophylaxis; Clindamycin; Clostridioides difficile; Drug-Related Side Effects and Adverse Reactions; Endocarditis; England; Humans; Incidence | 2015 |
Adverse drug reactions to treatments for ocular toxoplasmosis: a retrospective chart review.
Topics: Adolescent; Adult; Atovaquone; Clindamycin; Drug Combinations; Drug-Related Side Effects and Adverse Reactions; Exanthema; Female; Gastrointestinal Diseases; Humans; Male; Medical Records; Middle Aged; Pyrimethamine; Retrospective Studies; Sulfadiazine; Sulfamethoxazole; Toxoplasmosis, Ocular; Trimethoprim; Vitreous Body; Young Adult | 2008 |
Rare variations in IL36RN in severe adverse drug reactions manifesting as acute generalized exanthematous pustulosis.
Topics: Acute Generalized Exanthematous Pustulosis; Aged, 80 and over; Amoxicillin; Clindamycin; Drug-Related Side Effects and Adverse Reactions; Female; Genetic Variation; Heterozygote; Homozygote; Humans; Interleukins; Male; Middle Aged; Mutation, Missense; Piroxicam; Signal Transduction | 2013 |
Identification of adverse reactions to new drugs. II (continued): How were 18 important adverse reactions discovered and with what delays?
Topics: Anemia, Aplastic; Clindamycin; Drug and Narcotic Control; Drug-Related Side Effects and Adverse Reactions; Dyskinesia, Drug-Induced; Enterocolitis, Pseudomembranous; Humans; Lincomycin; Phenothiazines; Phenylbutazone; Safety; Tetracyclines; Time Factors; United Kingdom | 1983 |
[The relative therapeutic value of drugs in international comparison: differences between Switzerland and Canada].
Topics: Analgesics; Canada; Clindamycin; Drug Industry; Drug-Related Side Effects and Adverse Reactions; Enterocolitis, Pseudomembranous; Hydroxyquinolines; Switzerland; Therapeutic Equivalency | 1976 |